Who Supplies Chondroitin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Chondroitin exports, with 71+ registered manufacturers shipping to buyers across 70+ countries — yet a handful of companies dominate the shipments. PANACEA BIOTEC PHARMA LIMITED holds the largest share at 17.2% (export value: $874.4K). Close behind, MEDINOMICS HEALTH CARE PRIVATE LIMITED (16.7%, $848.3K). TROIKAA PHARMACEUTICALS LIMITED (11.1%, $565.4K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Chondroitin? Top Manufacturers & Their Buyers
Flow of Chondroitin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Chondroitin Supplier Network — Key Market Intelligence
The Chondroitin export market from India is led by PANACEA BIOTEC PHARMA LIMITED, which alone commands a 17.2% share, shipping $874.4K worth of product across 16 shipments. The second-largest exporter, MEDINOMICS HEALTH CARE PRIVATE LIMITED, contributes $848.3K (16.7%) to the overall market. Combined, the top two suppliers alone account for 33.9% of all Chondroitin exports, indicating a relatively concentrated supply base.
Across all 71 tracked manufacturers, the total Chondroitin export value stands at $5.1M from 349 shipments. The market average shipment value is $14.6K. The single largest buyer relationship in terms of trade value is FIDSON HEALTHCARE PLC, receiving $848.3K worth of product.
The combined buyer network spans 14 named purchasing companies, including PANBIO PHARM LLC, M S PANBIO PHARM LLC, FIDSON HEALTHCARE PLC, PLANET PHARMA, P P and 9 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1PANACEA BIOTEC PHARMA LIMITED
PANACEA BIOTEC PHARMA LIMITED is the first-largest Chondroitin exporter from India, with a market share of 17.2% and a total export value of $874.4K across 16 shipments. Their average shipment value of $54.6K is above the market average of $14.6K, suggesting premium or bulk contract pricing.
PANACEA BIOTEC PHARMA LIMITED serves 2 named buyers in our database. PANBIO PHARM LLC is the dominant customer, accounting for 78.2% of this supplier's tracked business. Top customers include:
• PANBIO PHARM LLC — $683.4K across 13 shipments (78.2% of this supplier's total exports)
• M S PANBIO PHARM LLC — $191.0K across 3 shipments (21.8% of this supplier's total exports)
Key Insight: PANACEA BIOTEC PHARMA LIMITED's per-shipment value of $54.6K is 275% above the market average of $14.6K, consistent with large-order contracts or value-added formulations.
2MEDINOMICS HEALTH CARE PRIVATE LIMITED
MEDINOMICS HEALTH CARE PRIVATE LIMITED is the second-largest Chondroitin exporter from India, with a market share of 16.7% and a total export value of $848.3K across 16 shipments. Their average shipment value of $53.0K is above the market average of $14.6K, suggesting premium or bulk contract pricing.
MEDINOMICS HEALTH CARE PRIVATE LIMITED serves 1 named buyer in our database. FIDSON HEALTHCARE PLC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• FIDSON HEALTHCARE PLC — $848.3K across 16 shipments (100.0% of this supplier's total exports)
Key Insight: MEDINOMICS HEALTH CARE PRIVATE LIMITED's per-shipment value of $53.0K is 264% above the market average of $14.6K, consistent with large-order contracts or value-added formulations.
3TROIKAA PHARMACEUTICALS LIMITED
TROIKAA PHARMACEUTICALS LIMITED is the third-largest Chondroitin exporter from India, with a market share of 11.1% and a total export value of $565.4K across 29 shipments. Their average shipment value of $19.5K is above the market average of $14.6K, suggesting premium or bulk contract pricing.
TROIKAA PHARMACEUTICALS LIMITED serves 5 named buyers in our database. PLANET PHARMA is the dominant customer, accounting for 75.3% of this supplier's tracked business. Top customers include:
• PLANET PHARMA — $425.6K across 22 shipments (75.3% of this supplier's total exports)
• PLANET PHARMA — $54.9K across 3 shipments (9.7% of this supplier's total exports)
• P P — $42.0K across 2 shipments (7.4% of this supplier's total exports)
• ABACUS PHARMA (A) LI — $28.5K across 1 shipments (5.0% of this supplier's total exports)
• P P — $14.4K across 1 shipments (2.5% of this supplier's total exports)
Key Insight: TROIKAA PHARMACEUTICALS LIMITED's per-shipment value of $19.5K is 34% above the market average of $14.6K, consistent with large-order contracts or value-added formulations.
4ORGANOSYN LIFE SCIENCES PRIVATE LIMITED
ORGANOSYN LIFE SCIENCES PRIVATE LIMITED is the fourth-largest Chondroitin exporter from India, with a market share of 8.2% and a total export value of $419.3K across 14 shipments. Their average shipment value of $29.9K is above the market average of $14.6K, suggesting premium or bulk contract pricing.
ORGANOSYN LIFE SCIENCES PRIVATE LIMITED serves 1 named buyer in our database. ORGANOSYN LIMITED LLC is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• ORGANOSYN LIMITED LLC — $419.3K across 14 shipments (100.0% of this supplier's total exports)
Key Insight: ORGANOSYN LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $29.9K is 106% above the market average of $14.6K, consistent with large-order contracts or value-added formulations.
5AUROLAB
AUROLAB is the fifth-largest Chondroitin exporter from India, with a market share of 8.0% and a total export value of $404.6K across 21 shipments. Their average shipment value of $19.3K is above the market average of $14.6K, suggesting premium or bulk contract pricing.
AUROLAB serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• RUMEX MEDICAL LLC — $191.0K across 10 shipments (47.2% of this supplier's total exports)
• FADY EXPRESS CARGO S — $172.1K across 9 shipments (42.6% of this supplier's total exports)
• ASG INVERSIONES EIRL — $26.8K across 1 shipments (6.6% of this supplier's total exports)
• PT MEDEQ MANDIRI UTA — $8.6K across 0 shipments (2.1% of this supplier's total exports)
• APEX VISION — $5.9K across 0 shipments (1.5% of this supplier's total exports)
Key Insight: AUROLAB's per-shipment value of $19.3K is 32% above the market average of $14.6K, consistent with large-order contracts or value-added formulations.
6AUROCHEM PHARMACEUTICALS (INDIA) PRIVATELIMITED
AUROCHEM PHARMACEUTICALS (INDIA) PRIVATELIMITED is the fifth-largest Chondroitin exporter from India, with a market share of 4.1% and a total export value of $207.7K across 19 shipments. Their average shipment value of $10.9K is below the market average of $14.6K, reflecting a high-volume, competitive pricing strategy.
AUROCHEM PHARMACEUTICALS (INDIA) PRIVATELIMITED serves 4 named buyers in our database. M/S PLANET PHARMA is the dominant customer, accounting for 59.3% of this supplier's tracked business. Top customers include:
• M/S PLANET PHARMA — $123.1K across 11 shipments (59.3% of this supplier's total exports)
• M/S PLANET PHARMA — $45.2K across 4 shipments (21.8% of this supplier's total exports)
• M/S PLANET PHARMA — $33.8K across 3 shipments (16.3% of this supplier's total exports)
• LABORATORIOS FARSIMA — $5.6K across 1 shipments (2.7% of this supplier's total exports)
Key Insight: AUROCHEM PHARMACEUTICALS (INDIA) PRIVATELIMITED operates with high shipment frequency (19 shipments) at a per-shipment value of $10.9K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Chondroitin Flows
Once Chondroitin leaves the manufacturing plants of companies like PANACEA BIOTEC PHARMA LIMITED and MEDINOMICS HEALTH CARE PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $5.1M. Russia absorbs the largest share at 22.5% ($1.1M), followed by Nigeria (21.6%) and France (19.4%).
In Russia — the top destination — named importers include PANBIO PHARM LLC, RUMEX MEDICAL LLC, M S PANBIO PHARM LLC. In Nigeria, key buyers are FIDSON HEALTHCARE PLC, GOLDMOORE INTERNATIONAL LTD.
This geographic spread reflects Chondroitin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Chondroitin Go? Top Importing Countries & Their Buyers
Trade flow of Chondroitin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Russia
Russia ranks as the first-largest destination for Chondroitin imports from India, with a total trade value of $1.1M across 20 shipments — representing a 22.5% share of all Chondroitin exports. The average shipment value of $57.2K is above the global average of $14.6K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Chondroitin importers in Russia: PANBIO PHARM LLC is the largest buyer, accounting for 59.8% ($683.4K) of this market's total imports.
• PANBIO PHARM LLC — $683.4K (59.8% of Russia's total)
• RUMEX MEDICAL LLC — $191.0K (16.7% of Russia's total)
• M S PANBIO PHARM LLC — $191.0K (16.7% of Russia's total)
Key Insight: Russia's per-shipment average of $57.2K (293% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Russia is a key market for Chondroitin imports from India.
2Nigeria
Nigeria ranks as the second-largest destination for Chondroitin imports from India, with a total trade value of $1.1M across 18 shipments — representing a 21.6% share of all Chondroitin exports. The average shipment value of $61.1K is above the global average of $14.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Chondroitin importers in Nigeria: FIDSON HEALTHCARE PLC is the largest buyer, accounting for 77.1% ($848.3K) of this market's total imports.
• FIDSON HEALTHCARE PLC — $848.3K (77.1% of Nigeria's total)
• GOLDMOORE INTERNATIONAL LTD — $68.1K (6.2% of Nigeria's total)
Key Insight: Nigeria's per-shipment average of $61.1K (320% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Nigeria is a key market for Chondroitin imports from India.
3France
France ranks as the third-largest destination for Chondroitin imports from India, with a total trade value of $984.5K across 37 shipments — representing a 19.4% share of all Chondroitin exports. The average shipment value of $26.6K is above the global average of $14.6K, indicating high-value procurement contracts or branded formulations. This market is served by 5 tracked buyers.
Named Chondroitin importers in France: PLANET PHARMA is the largest buyer, accounting for 43.2% ($425.6K) of this market's total imports.
• PLANET PHARMA — $425.6K (43.2% of France's total)
• M/S PLANET PHARMA — $123.1K (12.5% of France's total)
• M/S.PLANET PHARMA — $85.5K (8.7% of France's total)
Key Insight: France's per-shipment average of $26.6K (83% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
France is a key market for Chondroitin imports from India.
4Ukraine
Ukraine ranks as the fourth-largest destination for Chondroitin imports from India, with a total trade value of $417.9K across 14 shipments — representing a 8.2% share of all Chondroitin exports. The average shipment value of $29.8K is above the global average of $14.6K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Chondroitin importers in Ukraine: ORGANOSYN LIMITED LLC is the largest buyer, accounting for 100.3% ($419.3K) of this market's total imports.
• ORGANOSYN LIMITED LLC — $419.3K (100.3% of Ukraine's total)
Key Insight: Ukraine's per-shipment average of $29.8K (105% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ukraine is a key market for Chondroitin imports from India.
5United Arab Emirates
United Arab Emirates ranks as the fifth-largest destination for Chondroitin imports from India, with a total trade value of $209.5K across 0 shipments — representing a 4.1% share of all Chondroitin exports. The average shipment value of $209.5K is above the global average of $14.6K, indicating high-value procurement contracts or branded formulations.
Key Insight: United Arab Emirates's per-shipment average of $209.5K (1338% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Arab Emirates is a key market for Chondroitin imports from India.
People Also Ask — Chondroitin Supplier & Trade Network
Who are the top suppliers of Chondroitin from India?+
Which companies buy Chondroitin from Indian manufacturers?+
Where does Chondroitin exported from India go?+
What is the market share of the top Chondroitin supplier from India?+
What is the average shipment value for Chondroitin exports from India?+
Is Chondroitin manufactured in India and exported globally?+
Which country imports the most Chondroitin from India?+
Who are the buyers of Chondroitin in Nigeria?+
How concentrated is the Chondroitin supplier market in India?+
How do I find verified buyers for Chondroitin in specific countries?+
Chondroitin Trade Network — Key Takeaways
- 1PANACEA BIOTEC PHARMA LIMITED is India's dominant Chondroitin exporter with a 17.2% market share and $874.4K in total exports — making it the single most important sourcing entity in this market.
- 2The top 71 suppliers collectively account for 65.3% of all tracked Chondroitin exports, with a combined trade value of $5.1M.
- 3Russia is the largest destination market, absorbing 22.5% of India's Chondroitin exports ($1.1M). Nigeria (21.6%) and France (19.4%) follow.
- 4With 349 total shipments averaging $14.6K each, the Chondroitin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include PANBIO PHARM LLC, M S PANBIO PHARM LLC, FIDSON HEALTHCARE PLC, PLANET PHARMA — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 2 customers
6 suppliers → 70 countries
Network value: $5.1M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Chondroitin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Chondroitin.
- 2.Flow Mapping: 71 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 349 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 70 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
349 Verified Shipments
71 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists